These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37073874)

  • 21. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
    Assunção SS; Sperling RA; Ritchie C; Kerwin DR; Aisen PS; Lansdall C; Atri A; Cummings J
    Alzheimers Res Ther; 2022 Apr; 14(1):54. PubMed ID: 35440022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
    Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE
    PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients.
    Boccardi M; Nicolosi V; Festari C; Bianchetti A; Cappa S; Chiasserini D; Falini A; Guerra UP; Nobili F; Padovani A; Sancesario G; Morbelli S; Parnetti L; Tiraboschi P; Muscio C; Perani D; Pizzini FB; Beltramello A; Salvini Porro G; Ciaccio M; Schillaci O; Trabucchi M; Tagliavini F; Frisoni GB
    Eur J Neurol; 2020 Mar; 27(3):475-483. PubMed ID: 31692118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects.
    Rostamzadeh A; Schwegler C; Gil-Navarro S; Rosende-Roca M; Romotzky V; Ortega G; Canabate P; Moreno M; Schmitz-Luhn B; Boada M; Jessen F; Woopen C
    J Alzheimers Dis; 2021; 80(2):601-617. PubMed ID: 33554900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
    Karpouzian-Rogers T; Ho E; Novack M; Chinkers M; Bedjeti K; Nowinski C; Giordani B; Gershon R; Weintraub S
    Alzheimers Dement; 2023 May; 19(5):1974-1982. PubMed ID: 36396612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting.
    Cordell CB; Borson S; Boustani M; Chodosh J; Reuben D; Verghese J; Thies W; Fried LB;
    Alzheimers Dement; 2013 Mar; 9(2):141-50. PubMed ID: 23265826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people.
    Takechi H; Yoshino H
    Geriatr Gerontol Int; 2021 Feb; 21(2):192-196. PubMed ID: 33336432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment in older people.
    Burns A; Zaudig M
    Lancet; 2002 Dec; 360(9349):1963-5. PubMed ID: 12493278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.
    Liss JL; Seleri Assunção S; Cummings J; Atri A; Geldmacher DS; Candela SF; Devanand DP; Fillit HM; Susman J; Mintzer J; Bittner T; Brunton SA; Kerwin DR; Jackson WC; Small GW; Grossberg GT; Clevenger CK; Cotter V; Stefanacci R; Wise-Brown A; Sabbagh MN
    J Intern Med; 2021 Aug; 290(2):310-334. PubMed ID: 33458891
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.